IL322260A - טיפול במחלות פסיכיאטריות או נוירולוגיות על ידי מתן פרנטרלי של מינון פרנטרלי יחיד ואפקטיבי של חומר פסיכדלי קצר פעולה - Google Patents
טיפול במחלות פסיכיאטריות או נוירולוגיות על ידי מתן פרנטרלי של מינון פרנטרלי יחיד ואפקטיבי של חומר פסיכדלי קצר פעולהInfo
- Publication number
- IL322260A IL322260A IL322260A IL32226025A IL322260A IL 322260 A IL322260 A IL 322260A IL 322260 A IL322260 A IL 322260A IL 32226025 A IL32226025 A IL 32226025A IL 322260 A IL322260 A IL 322260A
- Authority
- IL
- Israel
- Prior art keywords
- dimethyltryptamine
- administration
- parenteral
- pharmaceutically acceptable
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363481040P | 2023-01-23 | 2023-01-23 | |
| US202363488613P | 2023-03-06 | 2023-03-06 | |
| PCT/EP2024/051569 WO2024156713A1 (en) | 2023-01-23 | 2024-01-23 | Treatment of psychiatric or neurological disorders by parenteral administration of a single, effective parenteral dose of a short-acting psychedelic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL322260A true IL322260A (he) | 2025-09-01 |
Family
ID=89723051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL322260A IL322260A (he) | 2023-01-23 | 2024-01-23 | טיפול במחלות פסיכיאטריות או נוירולוגיות על ידי מתן פרנטרלי של מינון פרנטרלי יחיד ואפקטיבי של חומר פסיכדלי קצר פעולה |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4654967A1 (he) |
| JP (1) | JP2026501897A (he) |
| KR (1) | KR20250136896A (he) |
| CN (1) | CN121038789A (he) |
| AU (1) | AU2024212866A1 (he) |
| IL (1) | IL322260A (he) |
| WO (1) | WO2024156713A1 (he) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114829341B (zh) | 2019-11-07 | 2024-03-08 | 赛本英国有限公司 | 合成方法 |
| US11759452B2 (en) | 2020-05-08 | 2023-09-19 | Psilera Inc. | Compositions of matter and pharmaceutical compositions |
| EP4153564A4 (en) | 2020-05-19 | 2024-06-19 | Cybin IRL Limited | DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE |
| BR112023001967A2 (pt) | 2020-08-05 | 2023-02-28 | Univ Basel | Método para induzir um estado psicodélico em um indivíduo, método para induzir um estado psicodélico em um indivíduo com segurança, método para fornecer um tratamento psicodélico de curta duração, método para determinar uma dose de dmt para um indivíduo, método para terapia e método para ajustar um estado psicodélico em um indivíduo em tempo real |
| PL4138818T3 (pl) | 2020-08-28 | 2024-11-12 | Cybin Uk Ltd | Preparat wstrzykiwalny |
| US11406619B2 (en) | 2020-08-28 | 2022-08-09 | Small Pharma Ltd | Injectable formulations |
| US11000534B1 (en) * | 2020-10-08 | 2021-05-11 | Lennham Pharmaceuticals, Inc. | Deuterated derivatives of psilocybin and uses thereof |
| WO2022082058A1 (en) * | 2020-10-16 | 2022-04-21 | Eleusis Therapeutics Us, Inc. | Method of treatment by tryptamine alkaloids |
| WO2022117359A1 (en) | 2020-12-01 | 2022-06-09 | Small Pharma Ltd | Deuterated or partially deuterated n,n-dimethyltryptamine compounds |
| WO2022117640A1 (en) | 2020-12-01 | 2022-06-09 | Small Pharma Ltd | Inhalable formulations |
| US11660289B2 (en) | 2020-12-01 | 2023-05-30 | Small Pharma Ltd. | Deuterated or partially deuterated N,N-dimethyltryptamine compounds |
| JP2024510637A (ja) | 2021-03-15 | 2024-03-08 | トライプ セラピューティクス インコーポレイテッド | サイケデリックの使用のための改善された方法 |
-
2024
- 2024-01-23 AU AU2024212866A patent/AU2024212866A1/en active Pending
- 2024-01-23 EP EP24702075.3A patent/EP4654967A1/en active Pending
- 2024-01-23 WO PCT/EP2024/051569 patent/WO2024156713A1/en not_active Ceased
- 2024-01-23 KR KR1020257027840A patent/KR20250136896A/ko active Pending
- 2024-01-23 JP JP2025542221A patent/JP2026501897A/ja active Pending
- 2024-01-23 IL IL322260A patent/IL322260A/he unknown
- 2024-01-23 CN CN202480014812.3A patent/CN121038789A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024212866A1 (en) | 2025-08-07 |
| JP2026501897A (ja) | 2026-01-16 |
| WO2024156713A1 (en) | 2024-08-02 |
| EP4654967A1 (en) | 2025-12-03 |
| KR20250136896A (ko) | 2025-09-16 |
| CN121038789A (zh) | 2025-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100888275B1 (ko) | 코 투여용 펜타닐 조성물 | |
| US6211194B1 (en) | Solution containing nicotine | |
| WO2024200710A1 (en) | Combination comprising a monoamine antidepressant agent and a short-duration psychedelic agent | |
| KR100425045B1 (ko) | 약물중독의치료를위한멜라토닌함유약학적조성물 | |
| RU2268725C2 (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств | |
| Aslani et al. | Design, formulation and evaluation of nicotine chewing gum | |
| Kotlyar et al. | Managing nicotine addiction | |
| EP4601639A1 (en) | Method of administration of a parenteral formulation comprising a psychedelic agent | |
| US20080131532A1 (en) | Fast asleep | |
| IL322260A (he) | טיפול במחלות פסיכיאטריות או נוירולוגיות על ידי מתן פרנטרלי של מינון פרנטרלי יחיד ואפקטיבי של חומר פסיכדלי קצר פעולה | |
| Pedersen | Treatment of nocturnal asthma in children with a single dose of sustained‐release theophylline taken after supper | |
| Jorenby et al. | Comparative efficacy and tolerability of nicotine replacement therapies | |
| WO2026013174A1 (en) | Pharmaceutical compositions comprising deuterated n,n-dimethyltryptamine | |
| CN109475538A (zh) | 使用异丁司特治疗酗酒和抑郁和/或焦虑情绪 | |
| RU2372915C2 (ru) | Применение трипролидина в обеспечении бодрости при пробуждении | |
| Ostrowski et al. | Pharmacologic management of patients using smoking cessation aids | |
| CN120813353A (zh) | 用于治疗勃起功能障碍的化合物 | |
| CN120754208A (zh) | 一种辅助控烟和提神的穴位按摩精油及其制备方法 | |
| CN118973569A (zh) | 用于治疗双相情感障碍的5-甲氧基-n,n-二甲基色胺 | |
| US20190008188A1 (en) | Antihistamines Combined with Dietary Supplements for Improved Health | |
| Erdemoglu | The administration of sumatriptan for the relief of headache in serotonin syndrome | |
| Shiffman et al. | Nicotine Delivery Systems | |
| Rosenberg et al. | Novel (Atypical) Antidepressants | |
| HK1089106B (en) | Fentanyl salt composition for nasal administration |